在clinicaltrials.gov注册的败血症试验的结果报告和早期中止
Handan Hu1, Xinyi Wang2, Peng Huang3,4
1Queen Mary School, Nanchang University, Nanchang, P. R. China.
Journal of evidence-based medicine
|July 3, 2023
概括
败血症临床试验经常提前停止 (12%) 并未报告结果 (91.6%). 美国注册的试验和较小的样本大小增加了中止风险,而非美国注册与报告不足有关.
科学领域:
- 关键护理医学 关键护理医学
- 临床试验方法论 临床试验方法论
- 传染病研究传染病研究.
背景情况:
- 败血症是全球主要的感染和伤害死亡原因之一.
- 了解影响败血症临床试验结果的因素对于推进患者护理至关重要.
- 之前的研究还没有充分解决试验中止率和预测因素以及结果报告不足的问题.
研究的目的:
- 在clinicaltrials.gov.gov上注册的败血症临床试验的特征.
- 为了确定与过早停止败血症试验相关的特征.
- 确定与败血症研究中报告结果缺乏相关的因素.
主要方法:
- 在clinicaltrials.gov系统搜索干预性败血症试验,直到2022年7月.
- 提取和审查结构化试验数据.
- 描述性分析,Cox和后勤回归以确定早期终止和报告不足的预测因素.
主要成果:
- 在1061个符合条件的败血症试验中,12.0%的试验被中止,91.6%的结果被报告不足.
- 美国注册的试验和更小的样本大小与更高的断药风险有关.
- 非美国注册的试验更有可能报告不足的结果.
结论:
- 试验中断率高,结果报告不足,严重阻碍了败血症研究和管理.
- 解决早期终止和改善结果传播对于推进败血症护理至关重要.
- 需要进一步的策略来加强败血症临床试验的完成和报告.
相关概念视频
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Pharmacovigilance
903
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
903
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Types of Reports III: Telephone and Verbal Reports
777
Telephone and Verbal Reports in healthcare settings are two communication methods for conveying therapeutic instructions from healthcare providers to nurses or other healthcare staff.
Here's an overview of each type:
Telephone Orders
Here's an overview of each type:
Telephone Orders
777
Hazard Ratio
165
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
165


